Clearstone Central Laboratories announced that business analytics software giant SAS has recently published a customer success story that features the extensive history between the two companies working alongside to accelerate clinical trails with clean, on-time data.
Every year, pharmaceutical companies deliver an ever-broadening range of medications that improve patient health and save countless lives. But the clinical trial phase of drug development is a risky proposition—expensive, highly regulated, and critical to the market approval of a drug. Increasingly, pharmaceutical executives are turning to Clearstone to manage this complex process of creating, aggregating, and delivering highly structured, reliable, and timely data.
SAS has allowed Clearstone to effectively work with large volumes of data that previously would require substantially more time and resources. Multiple tasks can be run simultaneously, allowing for time efficiencies. This additional flexibility has enabled Clearstone to rapidly scale its business around the world and expand its service offering to include data mining and analytical services that allow Clearstone to predict aspects of a trial using historical data.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.